{"name": "Innovative Biologics",
 "permalink": "innovative-biologics",
 "crunchbase_url": "http://www.crunchbase.com/company/innovative-biologics",
 "homepage_url": "http://www.innovbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "IBI",
 "email_address": "vak@innovbio.com",
 "phone_number": "703-622-5749",
 "description": "",
 "created_at": "Tue Mar 23 04:09:49 UTC 2010",
 "updated_at": "Tue Mar 23 04:20:23 UTC 2010",
 "overview": "\u003Cp\u003EInnovative Biologics (IBI) is an anti-infective small molecule drug\ndiscovery and development company targeting microbes producing pore-forming toxins, such as MRSA and Hepatitis C. Many pathogens utilize the formation of pores in the membranes of target cells in the process of infection. IBI has developed the CycloPlex\u00e2\u201e\u00a2 platform to identify compounds which inhibit their action, based on blocking the target pore with molecules having the same symmetry as the pore itself, using \u00c3\u0178-cyclodextrin as a scaffold.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[100,
       108],
      "assets/images/resized/0008/1334/81334v1-max-150x150.jpg"],
     [[100,
       108],
      "assets/images/resized/0008/1334/81334v1-max-250x250.jpg"],
     [[100,
       108],
      "assets/images/resized/0008/1334/81334v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$100k",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.cit.org/sites/default/files/file/GAPFund/pressreleases/071002-innovative_biologics.pdf",
    "source_description": "CIT GAP FUNDS INVESTS IN INNOVATIVE BIOLOGICS, INC.",
    "raised_amount": 100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CIT GAP Funds",
         "permalink": "cit-gap-funds-2",
         "image":
          {"available_sizes":
            [[[150,
               75],
              "assets/images/resized/0002/8818/28818v2-max-150x150.png"],
             [[218,
               110],
              "assets/images/resized/0002/8818/28818v2-max-250x250.png"],
             [[218,
               110],
              "assets/images/resized/0002/8818/28818v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "13455 Sunrise Valley Drive",
    "address2": "Suite 200",
    "zip_code": "20171",
    "city": "Herndon",
    "state_code": "VA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        101],
       "assets/images/resized/0008/1335/81335v1-max-150x150.jpg"],
      [[250,
        168],
       "assets/images/resized/0008/1335/81335v1-max-250x250.jpg"],
      [[450,
        304],
       "assets/images/resized/0008/1335/81335v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}